Market Expansion:
National and payer footprint have broadened materially, with availability across all 50 states, plan relationships rising toward 100+, and sharp increases in providers, patients, and appointments. This widening reach indicates an ability to capture demand across geographies and insurance lines.
Investor Backing & Capital Strength:
A $100M Series D at a roughly $2.3B valuation alongside substantial prior financing reflects strong access to growth capital. This position supports continued scaling of the network, product investments, and deeper insurer integrations.
Strong Revenue Growth:
Revenue is described as having increased significantly over a recent 12‑month period, with earlier disclosures citing outsized year‑over‑year gains. Coupled with rising session volumes, this points to robust top‑line momentum despite limited public financial detail.
